CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 51 filers reported holding CIDARA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $603,000 | +3.3% | 358,963 | +63.0% | 0.30% | +18.8% |
| Q1 2019 | $584,000 | +1.0% | 220,264 | -10.4% | 0.26% | -14.1% |
| Q4 2018 | $578,000 | -59.6% | 245,764 | -24.4% | 0.30% | -62.6% |
| Q3 2018 | $1,430,000 | -76.3% | 324,902 | -72.0% | 0.80% | -82.0% |
| Q2 2018 | $6,025,000 | +26.9% | 1,158,700 | -2.3% | 4.42% | +48.4% |
| Q1 2018 | $4,746,000 | -57.6% | 1,186,355 | -28.0% | 2.98% | -63.9% |
| Q4 2017 | $11,206,000 | – | 1,647,879 | – | 8.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |